bims-nimamd Biomed News
on Neuroimmunity and neuroinflammation in ageing and metabolic disease
Issue of 2026–11–15
25 papers selected by
Fawaz Alzaïd, Sorbonne Université



  1. Science. 2026 Nov 12. 394(6825): 731
      Discovery of an unknown immune cell type and its cytotoxic killing mode.
    DOI:  https://doi.org/10.1126/science.aen0894
  2. Nature. 2026 Nov 09.
      
    Keywords:  Funding; Government; Institutions
    DOI:  https://doi.org/10.1038/d41586-026-02998-0
  3. Immunity. 2026 Nov 10. pii: S1074-7613(26)00435-8. [Epub ahead of print]59(11): 2882-2884
      Trans-splicing of pre-mRNAs to produce alternate proteins is known to occur in unicellular and invertebrate organisms; yet whether such events occur and produce functional proteins in mammals remains unclear. In a recent issue of Nature, macrophages polarized to an inflammatory state were found to produce several chimeric RNAs through trans-splicing with consequences for the inflammatory response.
    DOI:  https://doi.org/10.1016/j.immuni.2026.10.009
  4. Nat Commun. 2026 10 13. pii: 11577. [Epub ahead of print]17(1):
      Impaired adipogenesis contributes to obesity-associated metabolic disorders, in which mitochondrial dysfunction plays an important role. Emerging evidence suggests that mitochondria-localized circular RNAs (circRNAs) influence mitochondrial function; however, whether they regulate adipogenesis and systemic metabolism is unclear. By profiling circRNAs in mitochondria isolated from the white adipose tissue (WAT) of obese male mice, we observe an upregulation of Birc6-circRNA Repressing Adipogenesis and Krebs-cycle Energy (BRAKE) in mitochondria. In vivo, adipocyte-specific circRNA BRAKE knockdown in male mice reduces body weight, restricts fat expansion, and improves insulin sensitivity. In vitro studies show that circRNA BRAKE inhibits adipogenesis. Mechanistically, circRNA BRAKE binds ATP5A and disrupts ATP synthase assembly, thereby reducing ATP production and mTORC1 signaling and suppressing adipogenesis. In omental WAT (oWAT) of patients with obesity, mitochondrial circRNA BRAKE levels are elevated and inversely correlated with mitochondrial bioenergetic function. Collectively, our data identify a mitochondria-localized circRNA that regulates energy metabolism and adipogenesis, suggesting that circRNA BRAKE may represent a potential therapeutic target for obesity-related metabolic diseases.
    DOI:  https://doi.org/10.1038/s41467-026-78378-z
  5. Immunity. 2026 Nov 10. pii: S1074-7613(26)00436-X. [Epub ahead of print]59(11): 2879-2881
      Metabolites can regulate T cell gene expression and effector function, but how changes in mitochondrial ATP production influence chromatin remodeling remains unclear. In a recent issue of Cell, Ng et al. demonstrate that D-α-hydroxybutyrate (DAHB) increases oxidative phosphorylation and phosphocreatine production, promoting chromatin accessibility and CD8+ T cell effector function to limit tumor growth.
    DOI:  https://doi.org/10.1016/j.immuni.2026.10.010
  6. Nat Aging. 2026 Nov 11.
      Aging is associated with a progressive decline in immune surveillance, yet the mechanisms that constrain this process remain incompletely understood. Here we uncover a lipid-biomechanical mechanism in human natural killer (NK) cells that contributes to age-related immune decline. We show that aging drives a coordinated metabolic and physical state in NK cells, marked by lipid accumulation, increased membrane fluidity, reduced cortical stiffness and defective immune synapse organization, ultimately impairing target cell killing. Mechanistically, aging induces a retinoid-dependent metabolic shift in NK cells, characterized by enhanced retinol uptake and intracellular retinoic acid accumulation, which activates an SREBP1-dependent lipogenic program with ELOVL6 as a key downstream effector. This program remodels fatty-acyl composition, alters membrane and cortical mechanics, and constrains NK cell cytotoxic function. ELOVL6 inhibition restores membrane and cortical mechanics, rescues cytotoxicity in vitro and enhances antitumor activity in mouse models. These findings establish a targetable biomechanical mechanism linking aging to impaired immune surveillance.
    DOI:  https://doi.org/10.1038/s43587-026-01262-4
  7. Nature. 2026 Nov 11.
      
    Keywords:  Epidemiology; Medical research; Obesity
    DOI:  https://doi.org/10.1038/d41586-026-03636-5
  8. Cell. 2026 Nov 12. pii: S0092-8674(26)01116-5. [Epub ahead of print]189(23): 7571-7592.e7
    Cayo Biobank Research Unit
      Brain aging is a complex process with profound health and societal consequences. However, the molecular and cellular pathways that govern its progression, and inter- and intra-individual variation, remain poorly defined. We present a transcriptomic atlas of 5.3 million cells from 582 samples spanning 11 brain regions of 55 rhesus macaques (aged 0.5-21 years). We identify age-depleted and vulnerable neuronal populations and subtle, age-associated compositional differences in glia-detectable only at single-cell resolution. We chart convergent and divergent age-associated molecular signatures across regions and cell types, which include sex-specific signatures that could underlie biases in neurological disorders. These signatures overlap those of Alzheimer's disease (AD), which suggests that aging and AD share molecular roots that emerge at different ages and in region- and sex-specific windows of vulnerability. This work provides a temporal, regional, and sex-stratified atlas of the aging primate brain, offering insights into cell-type-specific vulnerabilities and regional heterogeneity with translational human relevance.
    Keywords:  aging; molecular aging; neurodegeneration; neuroscience; primate; sex differences; single-nucleus RNA sequencing
    DOI:  https://doi.org/10.1016/j.cell.2026.09.014
  9. Cell. 2026 Nov 12. pii: S0092-8674(26)01270-5. [Epub ahead of print]189(23): 7284-7286
      In this issue of Cell, two single-cell multiomic atlases jointly profile transcription and histone modifications across different regions of the adult human brain, revealing cell-type-specific regulatory landscapes, developmental epigenetic memory, and improved interpretation of neurological variants. These studies establish a framework for understanding human brain cell identity, evolution, and pathology.
    DOI:  https://doi.org/10.1016/j.cell.2026.10.020
  10. Nature. 2026 Nov;659(8140): 272
      
    Keywords:  Research data; Research management; Scientific community
    DOI:  https://doi.org/10.1038/d41586-026-03620-z
  11. Nat Metab. 2026 Nov 13.
      Brown adipose tissue (BAT) is a cold-activated organ that uncouples mitochondrial respiration from ATP synthesis to produce heat. Activated BAT can consume an extreme amount of glucose, per gram of tissue, in both mice and humans. However, the contexts, mechanisms and necessity for BAT glucose utilization remain surprisingly undefined in vivo. Here we show that while BAT thermogenesis is maintained across diverse dietary contexts, its glucose utilization is particularly responsive to diet. Importantly, we find cold-induced BAT glucose uptake and thermogenesis to be independent of the previously proposed critical transporter, GLUT1. Instead, inducible GLUT4 loss eliminates cold-induced glucose uptake and compromises BAT thermogenesis only when dietary lipids are low during cold stress. We furthermore illustrate the unexpected capacity for brown adipocytes to sustain ATP levels without glycolysis, even during substantial mitochondrial uncoupling, when alternative nutrients are abundant. Collectively, our work demonstrates that BAT sustains thermogenesis through marked metabolic flexibility across nutrient contexts.
    DOI:  https://doi.org/10.1038/s42255-026-01652-3
  12. J Clin Invest. 2026 Nov 12. pii: e205758. [Epub ahead of print]
      Epigenetic modifications contribute to lipid-related disorders by modulating the expression of key genes involved in lipid metabolism. Accumulating evidence suggests that lipid metabolism-mediated ferroptosis drives the progression of metabolic associated steatohepatitis (MASH) and liver injury. However, whether epigenetic mechanisms remodel lipid metabolism to regulate ferroptosis-induced liver damage remains unclear. Here, through pharmacological screening of epigenetics-related compounds and CRISPR-Cas9-based screening targeting epigenetic factors, we identified DOT1 Like Histone Lysine Methyltransferase (DOT1L) as a key sensitizer of hepatocytes to ferroptosis and subsequent liver injury, whereas inhibition of DOT1L reverses the phenomenon. DOT1L loss remodeled the phospholipid landscape by decreasing PUFA-containing phospholipids while increasing monounsaturated and lysophospholipid species. Mechanistically, DOT1L depletion reduced H3K79me1 and H3K79me2 occupancy at the PLA2G7, ALDH3B1, and PLCXD3 loci, particularly across gene-body regions, while increasing promoter-proximal accessibility and expression of these phospholipid-remodeling genes. These genes suppress ferroptosis by reducing the levels of phospholipids containing polyunsaturated fatty acids (PL-PUFAs). Furthermore, we demonstrated that AMPK phosphorylates DOT1L at Ser786, weakens its association with AF9, and suppresses H3K79 methyltransferase activity and ferroptosis sensitivity. Collectively, our findings reveal the AMPK-DOT1L-H3K79 methylation axis as a novel lipid metabolic pathway that regulates ferroptosis and maintains hepatic homeostasis, offering new therapeutic insights for ferroptosis-related liver injury.
    Keywords:  Cell biology; Hepatology; Lipidomics; Metabolism; Metabolomics
    DOI:  https://doi.org/10.1172/JCI205758
  13. Nat Commun. 2026 10 14. pii: 11622. [Epub ahead of print]17(1):
      Accessible cholesterol, the pool of membrane cholesterol with high chemical activity, regulates vital processes including vertebrate development and pathogen evasion. The mechanisms that govern plasma membrane (PM) cholesterol accessibility are incompletely understood. Using a genome-wide screen we find that acetyl-CoA carboxylase alpha (ACC1) loss causes a ~10-fold increase in PM accessible cholesterol in cells and a male mouse model. We demonstrate that reduced fatty acyl-CoA levels, achieved by targeting metabolic enzymes including ACC1, fatty acid synthase (FASN) or acyl-CoA synthetases long chain (ACSL1, 3 and 4), results in the activation of adipose triacylglycerol lipase (ATGL). ATGL activation elevates polyunsaturated diacylglycerols even in triacylglycerol-deficient backgrounds, suggesting that ATGL acts independently of triacylglycerol hydrolysis. These diacylglycerol species are utilized to generate polyunsaturated phosphatidylcholine and phosphatidylethanolamine, which raises PM fluidity and cholesterol accessibility. Conversely, ATGL inhibition rigidifies the PM, reducing PM accessible cholesterol. Increased PM fluidity impairs cholesterol transport, triggering SREBP2 activation. This study reveals a surprising link between fatty acid metabolism and cholesterol homeostasis, demonstrating how ATGL-dependent lipid remodeling tunes membrane fluidity to regulate intracellular cholesterol signaling.
    DOI:  https://doi.org/10.1038/s41467-026-78470-4
  14. Dev Cell. 2026 Nov 11. pii: S1534-5807(26)00399-0. [Epub ahead of print]61(11): 2098-2100
      Stem cell-derived islets offer a promising approach to restoring endogenous insulin secretion in type 1 diabetes (T1D). In this issue of Developmental Cell, Zhao, Liang et al. show that ISX-9 expands PDX1+/NKX6-1+ pancreatic progenitors and improves beta-like cell yield and function, while revealing how extracellular matrix signaling regulates progenitor identity.
    DOI:  https://doi.org/10.1016/j.devcel.2026.10.013
  15. J Clin Endocrinol Metab. 2026 Nov 07. pii: dgag456. [Epub ahead of print]
      Subcellular lipid localization in skeletal muscle associates with insulin sensitivity in humans, yet these lipid distributions do not substantially revert after 12 weeks of insulin-sensitizing lifestyle interventions. This suggests interventions may need to occur earlier, before prediabetes or type 2 diabetes develops, or that lipid localization responds rapidly to acute changes in energy balance and physical activity that may not be captured following typical weight loss or exercise training interventions. To address this gap, we assessed the effect of acute and chronic insulin-sensitizing interventions across a spectrum of metabolic health in three separate studies. Individuals with obesity and normal glucose tolerance (NGT, n= 35, 39.4±1.0 yrs, BMI 35.7±0.7) or prediabetes/type 2 diabetes (pre/T2D, n=34, 43.8±1.3 yrs, BMI 35.3±0.7) completed 12-week interventions (combined weight loss plus exercise, weight loss alone, exercise alone, or delayed control). Endurance-trained athletes (n=20, 27.3±1.2 yrs, BMI 22.1±0.4) performed 1.5 hours of acute exercise at 50% or 70% VO2max under fed and/or fasted conditions. Muscle biopsies obtained pre/post intervention or acute exercise were fractionated into sarcolemmal, mitochondrial/ER, cytosolic, and nuclear compartments and analyzed by targeted lipidomics. Triacylglycerols were inversely associated with insulin sensitivity across all compartments. Ceramides showed inverse associations in sarcolemmal, mitochondrial/ER, and nuclear fractions, but a positive association in the cytosol. In contrast, 1,2-DAGs were positively associated with insulin sensitivity in mitochondrial/ER, cytosolic, and nuclear compartments. Neither lifestyle interventions nor acute exercise substantially altered subcellular lipid distribution. Overall, subcellular lipid localization was strongly associated with insulin sensitivity yet changed inconsistently following acute and chronic interventions, regardless of metabolic status. These data suggest that more dramatic changes in weight and fitness, and/or interventions longer than 12 weeks may be required to modify muscle subcellular lipids linked to insulin resistance.
    Keywords:  Bioactive lipids; acute exercise; bioactive lipids; ectopic lipid accumulation; lipidomics; muscle quality; obesity; subcellular lipid localization
    DOI:  https://doi.org/10.1210/clinem/dgag456
  16. Nat Commun. 2026 11 06. pii: 11497. [Epub ahead of print]17(1):
      Neutrophil extracellular trap formation is a central innate immune defence mechanism that depends on NADPH oxidase-driven reactive oxygen species production. How NADP⁺ availability is regulated during neutrophil activation remains unclear. Using integrated lipidomic, biochemical and functional analyses in human neutrophils, we identify NAD kinase, the sole enzyme responsible for NADP⁺ synthesis, as a direct lipid-regulated effector downstream of phospholipase D1. Neutrophil activation induces rapid, phospholipase D1-dependent production of phosphatidic acid and phosphatidylinositol 4,5-bisphosphate, which bind and activate NAD kinase. The resulting cytosolic NADP⁺ is reduced to NADPH by the oxidative pentose phosphate pathway and consumed by NADPH oxidase during neutrophil extracellular trap formation. Pharmacological or genetic disruption of phospholipase D1 suppresses NAD kinase activity, depletes NADP⁺ and impairs neutrophil extracellular trap formation independently of direct NADPH oxidase inhibition. These findings define a lipid-metabolic axis coupling phospholipase D1-driven membrane remodelling to NADP⁺ availability and innate immune function.
    DOI:  https://doi.org/10.1038/s41467-026-79319-6
  17. JCI Insight. 2026 Nov 09. pii: e197382. [Epub ahead of print]11(21):
      Unhealthy nutrition in early life can reduce response to a weight loss drug in adult obesity.
    Keywords:  Development; Endocrinology; Glucose metabolism; Insulin; Metabolism; Obesity
    DOI:  https://doi.org/10.1172/jci.insight.197382
  18. Nature. 2026 Nov;659(8140): 290-292
      
    Keywords:  Alzheimer's disease; Genetics; Neurodegeneration
    DOI:  https://doi.org/10.1038/d41586-026-03625-8
  19. Nat Commun. 2026 10 14. pii: 11609. [Epub ahead of print]17(1):
      The autonomic sympathetic nervous system innervates peripheral resistance arteries, thereby controlling arterial diameter and modulating blood supply to organs and arterial tone. Despite its fundamental role in blood flow regulation and cardiovascular adaptation to challenging situations, how sympathetic arterial innervation develops remains poorly understood.We here show that sympathetic arterial innervation is regulated by the axonal guidance molecule EphrinA4 in arterial Smooth Muscle Cells (SMCs), which repels sympathetic axons via the EphA4 receptor. Using the EphA4flox-THCRE mouse, we specifically inactivated EphA4 in sympathetic axons, inducing a loss of repulsion and increased sympathetic innervation of peripheral arteries throughout life. Functional consequences included a significant increase in arterial tone, including resistivity and vasoconstriction, associated with elevated systemic arterial blood pressure at rest and a marked increase during acute stress. These findings identify a pathway that negatively regulates sympathetic arterial innervation and could contribute to elevated systemic blood pressure in male mice.
    DOI:  https://doi.org/10.1038/s41467-026-78388-x
  20. Nat Commun. 2026 10 12. pii: 11547. [Epub ahead of print]17(1):
    Mengzhen Li, Abdulgani Tatar, Emre Green, Ebru Simsek, Cigdem Yuce Kahraman, Mustafa Ceylan, Fuat Laloglu, Naci Ceviz, Arzu Tatar, Esra Laloglu, Gungor Akcay, Kenan Cadirci, Omer Erkan Yapca, Hilal Kiziltunc Ozmen, Turgut Yapanoglu, Ozlem Kudas, Fatma Simsek, Emsal Pinar Topdagi Yılmaz, Gamze Nur Cimilli Senocak, Hakan Doneray, Ayse Ozden, Atilla Cayir, Pinar Tosun Tasar, Mustafa Kara, Yunus Emre Aktaş, Mursel Karadavut, Busra Akpinar, Eyup Serhat Calik, Bilgehan Erkut, Mufide Akcay, Erdem Karadeniz, Murat Kartal, Esra Disci, Mehmet Ilhan Yildirgan, Sabri Selcuk Atamanalp, Rifat Peksoz, Yavuz Albayrak, Atilla Eroglu, Yener Aydın, Sultan Tuna Akgol Gur, Mevlana Gul, Erdal Tekin, Ali Bilal Ulas, Eyup Senocak, Ahmet Emre Paksoy, Ayse Sena Donmez, Mehmet Cenk Turgut, Ozgur Ozmen, Fatih Alper, Hasan Abbas Guliyev, Bulent Albayrak, Emine Cinici, Ibrahim Kocer, Esat Fahri Aydın, Nazim Dogan, Yahya Gul, Ugur Kaya, Yunus Emre Topdagi, Yakup Kumtepe, Aysenur Dostbil, Husnu Kursat, Nuray Bilge, Ozkan Cinici, Esra Disci, Derya Cevizli, Muhammed Akif Guler, Halil Ozcan, Tugba Koca Lacin, Serap Sari, Bugra Kerget, Omer Araz, Fatma Tortum, Necip Altundas, Nurhak Aksungur, Salih Kara, Gurkan Ozturk, Serap Kilic Kaya, Merve Ulku, Fatma Kesmez Can, Handan Alay, Ayse Albayrak, Kemalettin Ozden, Ertugrul Karatas, Mirze Muhammet Ozen, Ali Gur, Taner Arabaci, Sinan Yilar, Serdar Saritas, Zulal Ozkurt, Hacer Akgul Ceyhun, Can Sevinc, Mehmet Akif Sirin, Gulden Sincan, Momen Kanjee, Busra Saruhan, Sumeyye Ozturk Eren, Bahadir Utlu, Muhammed Hakan Tas, Esra Tanriverdi, María Bueno Álvez, Fredrik Edfors, Xiangtai Kong, Xiya Song, Ozlem Altay, Bayram Yuksel, Mathias Uhlen, Saeed Shoaie, Cheng Zhang, Hasan Turkez, Adil Mardinoglu.
      We present a WBT Atlas, comprising 4444 WBT samples across 98 distinct health conditions, enabling systematic exploration of disease-associated transcriptomic signatures. Health condition-specific profiles are characterized across immune, metabolic, and cell-type specific features at the gene, gene module, and pathway levels. By integrating matched plasma proteomics data from 1280 participants across 28 health conditions, we further assess blood RNA-protein relationships and demonstrate their complementary biological roles. By integrating RNA and protein signatures, we develop multi-class classification models that accurately distinguish among a wide range of health conditions, with integrated models consistently outperforming those based on single-omics data alone. The identified RNA and protein signatures are validated across ten independent WBT cohorts and the UK Biobank. Together, the WBT Atlas provides a genome-wide resource that enables translational discovery in precision medicine.
    DOI:  https://doi.org/10.1038/s41467-026-78440-w